Patent · US Active

Antiproliferative factor and methods of use

US9085604B2 · kind B2 · utility

0Cited by

7References

26Claims

0Family size

Assignees

UNIVERSITY OF MARYLAND, BALTIMORE · US
The United States of America as Represented by the Secretary of the Department of Health and Human Services · US
The United Sates of America, as Represented by the Department of Veterans Affairs · US

Inventors

Susan K. Keay · Ellicott City, US
Christopher J. Michejda · North Potomac, US
Zoltan Szekely · Frederick, US
Thomas P. Conrads · Reston, US
Timothy D. Veenstra · Jefferson, US

Key dates

Filing date	Dec 13, 2007
Grant date	Jul 21, 2015
Priority date	—
Expiry date	Feb 24, 2030

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K38/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A novel antiproliferative factor comprising a glycopeptide is disclosed. In specific embodiments, the novel antiproliferative factor is associated with the bladder. Compositions, diagnostic kits and reagents, and methods of using the compounds for identifying and/or treating interstitial cystitis and cancer are disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.